PRESS RELEASE published on 03/18/2025 at 09:50, 1 year 5 months ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social VALBIOTIS SA publie des informations mensuelles sur le nombre total de droits de vote et d'actions. L'entreprise se spécialise dans la commercialisation de compléments alimentaires pour la santé et la prévention des maladies métaboliques et cardiovasculaires Droits De Vote Informations Mensuelles Compléments Alimentaires Maladies Métaboliques Valbiotis SA
BRIEF published on 03/17/2025 at 17:45, 1 year 5 months ago Valbiotis Introduces Cholesterol Management Alternative Amid Regulatory Changes Regulation Valbiotis Lipidrive Cholesterol Management Red Yeast Rice
BRIEF published on 03/17/2025 at 17:45, 1 year 5 months ago Valbiotis présente une alternative de gestion du cholestérol dans un contexte de changements réglementaires Valbiotis Lipidrive Règlement Gestion Du Cholestérol Riz À Levure Rouge
PRESS RELEASE published on 03/17/2025 at 17:40, 1 year 5 months ago VALBIOTIS SA: In anticipation of a change in regulations, Valbiotis® offers a scientifically proven alternative to red yeast rice for cholesterol management Valbiotis® offers a scientifically proven alternative to red yeast rice for cholesterol management in response to changing regulations. Learn about Valbiotis®PRO Cholesterol Valbiotis Lipidrive Health Supplements Cholesterol Management Red Yeast Rice
PRESS RELEASE published on 03/17/2025 at 17:40, 1 year 5 months ago VALBIOTIS SA: Valbiotis® anticipe l’évolution de la réglementation et propose une alternative scientifiquement prouvée sans levure de riz rouge pour la gestion du cholestérol Valbiotis SA propose une alternative innovante, Lipidrive®, sans levure de riz rouge pour gérer le cholestérol, anticipant ainsi les nouvelles réglementations. Dossier pour allégation santé prévu en 2025 Réglementation Valbiotis Lipidrive Levure De Riz Rouge Cholestérol
BRIEF published on 03/03/2025 at 17:45, 1 year 5 months ago Résultats financiers 2024 et ambitions futures de Valbiotis Stratégie Financière Expansion Internationale Valbiotis Compléments Alimentaires Résultats 2024
BRIEF published on 03/03/2025 at 17:45, 1 year 5 months ago Valbiotis 2024 financial results and future ambitions Valbiotis International Expansion Financial Strategy Food Supplements Results 2024
PRESS RELEASE published on 03/03/2025 at 17:40, 1 year 5 months ago VALBIOTIS SA: Valbiotis dévoile ses comptes annuels et confirme ses ambitions stratégiques et financières Valbiotis SA dévoile ses comptes annuels et confirme ses ambitions stratégiques et financières. La société annonce des résultats solides et une feuille de route ambitieuse jusqu'en 2030 Commercialisation Comptes Annuels Valbiotis SA Feuille De Route Ambitions Stratégiques
PRESS RELEASE published on 03/03/2025 at 17:40, 1 year 5 months ago VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms its strategic and financial goals Valbiotis unveils its annual financial statements & confirms strategic and financial goals for 2027 & 2030. Company reports fiscal year 2024 results indicating progress and transformation Financial Statements Valbiotis Annual Results Strategic Goals Commercialization Phase
BRIEF published on 02/24/2025 at 10:18, 1 year 5 months ago VALBIOTIS : Bilan Mensuel des Droits de Vote et Actions Droits De Vote Capital Social Actions Euronext Growth Valbiotis
Published on 08/20/2026 at 15:30, 1 hour 43 minutes ago Caldwell Announces Promotion of Lindsay Schoen Lane to Partner
Published on 08/20/2026 at 15:15, 1 hour 58 minutes ago Reporting Results for the Six Months Ended June 30, 2026
Published on 08/20/2026 at 15:00, 2 hours 13 minutes ago Portfolio Update - Strategic Investment in Maravilla Oil and Gas
Published on 08/20/2026 at 15:00, 2 hours 13 minutes ago Vox Royalty Enters into Binding Agreement to Acquire Australian Copper and Gold Royalty Portfolio
Published on 08/20/2026 at 14:35, 2 hours 38 minutes ago Wi2Wi Reports 59% Revenue Growth to US$2.32M and Returns to Profitability with US$251K Net Income in Q2 2026
Published on 08/20/2026 at 15:45, 1 hour 27 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 08/20/2026 at 15:45, 1 hour 28 minutes ago Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 08/20/2026 at 15:44, 1 hour 29 minutes ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc
Published on 08/20/2026 at 15:43, 1 hour 30 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 08/18/2026 at 18:00, 1 day 23 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 1 day 23 hours ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 2 days 5 hours ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 2 days 5 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 2 days 21 hours ago Aéroports de Paris S.A - July 2026 traffic figures